Compare HYPR & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYPR | CTSO |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 49.7M |
| IPO Year | N/A | N/A |
| Metric | HYPR | CTSO |
|---|---|---|
| Price | $1.08 | $0.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $1.28 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 625.1K | 126.1K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,591,000.00 | ★ $36,979,520.00 |
| Revenue This Year | $5.17 | $9.51 |
| Revenue Next Year | $35.44 | $24.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.89 |
| 52 Week Low | $0.53 | $0.60 |
| 52 Week High | $2.22 | $1.61 |
| Indicator | HYPR | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 46.64 |
| Support Level | $0.85 | $0.70 |
| Resistance Level | $1.18 | $0.85 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 68.37 | 52.04 |
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.